Next Article in Journal
Albumin Nanovectors in Cancer Therapy and Imaging
Next Article in Special Issue
Role of Cop9 Signalosome Subunits in the Environmental and Hormonal Balance of Plant
Previous Article in Journal
Machine Learning for Molecular Modelling in Drug Design
Previous Article in Special Issue
In-depth Analysis of the Lid Subunits Assembly Mechanism in Mammals
Open AccessReview

Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases

Vascular Biology, Institute for Stroke and Dementia Research (ISD), Klinikum der Universität München (KUM), Ludwig-Maximilians-University (LMU), 81377 Munich, Germany
Munich Heart Alliance, 80802 Munich, Germany
Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
Author to whom correspondence should be addressed.
Biomolecules 2019, 9(6), 217;
Received: 29 April 2019 / Revised: 2 June 2019 / Accepted: 3 June 2019 / Published: 5 June 2019
(This article belongs to the Special Issue The Broader Cellular Impact of Proteasome-CSN-eIf3 (PCI) Complexes)
The constitutive photomorphogenesis 9 (COP9) signalosome (CSN) is an evolutionarily conserved multi-protein complex, consisting of eight subunits termed CSN1-CSN8. The main biochemical function of the CSN is the control of protein degradation via the ubiquitin-proteasome-system through regulation of cullin-RING E3-ligase (CRL) activity by deNEDDylation of cullins, but the CSN also serves as a docking platform for signaling proteins. The catalytic deNEDDylase (isopeptidase) activity of the complex is executed by CSN5, but only efficiently occurs in the three-dimensional architectural context of the complex. Due to its positioning in a central cellular pathway connected to cell responses such as cell-cycle, proliferation, and signaling, the CSN has been implicated in several human diseases, with most evidence available for a role in cancer. However, emerging evidence also suggests that the CSN is involved in inflammation and cardiovascular diseases. This is both due to its role in controlling CRLs, regulating components of key inflammatory pathways such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and complex-independent interactions of subunits such as CSN5 with inflammatory proteins. In this case, we summarize and discuss studies suggesting that the CSN may have a key role in cardiovascular diseases such as atherosclerosis and heart failure. We discuss the implicated molecular mechanisms ranging from inflammatory NF-κB signaling to proteotoxicity and necrosis, covering disease-relevant cell types such as myeloid and endothelial cells or cardiomyocytes. While the CSN is considered to be disease-exacerbating in most cancer entities, the cardiovascular studies suggest potent protective activities in the vasculature and heart. The underlying mechanisms and potential therapeutic avenues will be critically discussed. View Full-Text
Keywords: atherosclerosis; constitutive photomorphogenesis 9 (COP9) signalosome (CSN); cardiovascular diseases; deNEDDylation; heart failure; inflammation; JAB1; myocardial infarction; stroke atherosclerosis; constitutive photomorphogenesis 9 (COP9) signalosome (CSN); cardiovascular diseases; deNEDDylation; heart failure; inflammation; JAB1; myocardial infarction; stroke
Show Figures

Figure 1

MDPI and ACS Style

Milic, J.; Tian, Y.; Bernhagen, J. Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases. Biomolecules 2019, 9, 217.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop